• Mikroskopaufnahme

Welcome to the Hudecek Lab – The home of CAR T

Our research

We are developing novel personalized immune-based cancer treatments that involve reprogramming of the patient’s own immune system cells which are then used to target and destroy cancer cells.

Our approach

We are equipping T cells (white blood cells) with a biosensor (chimeric antigen receptor, CAR) to help them detect and eliminate cancer cells.

Latest publications

Luu, M, Visekruna, A (2022). Targeting metabolic rewiring might decrease spread of tumor cells: Mitochondrial tRNA modifications promote cancer metastasis. Sig Transduct Target Ther 7, 360.
Go to publication

Lock D, Monjezi R, Brandes C, et al (2022). Automated, scaled, transposon-based production of CAR T cells. Journal for ImmunoTherapy of Cancer;10.
Go to publication

Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, Casucci M, De Angelis B, Donnadieu E, Espie D, Greco B, Groen R, Huppa JB, Kantari-Mimoun C, Laugel B, Mantock M, Markman JL, Morris E, Quintarelli C, Rade M, Reiche K, Rodriguez-Garcia A, Rodriguez-Madoz JR, Ruggiero E, Themeli M, Hudecek M, Marchiq I (2022). Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside? J Immunother Cancer. May;10(5).
Go to publication

Donnadieu E, Luu M, Alb M, Anliker B, Arcangeli S, Bonini C, De Angelis B, Choudhary R, Espie D, Galy A, Holland C, Ivics Z, Kantari-Mimoun C, Kersten MJ, Köhl U, Kuhn C, Laugel B, Locatelli F, Marchiq I, Markman J, Moresco MA, Morris E, Negre H, Quintarelli C, Rade M, Reiche K, Renner M, Ruggiero E, Sanges C, Stauss H, Themeli M, Van den Brulle J, Hudecek M, Casucci M (2022). Time to evolve: predicting engineered T cell-associated toxicity with next-generation models. J Immunother Cancer. May;10(5).
Go to publication

Brosinsky P, Leister H, Cheng N, Varelas X, Visekruna A, Luu M (2022). Verteporfin protects against Th17 cell-mediated EAE independent of YAP inhibition. Eur J Immunol. 
Go to publication

Maucher M, Srour M, Danhof S, Einsele H, Hudecek M, Yakoub-Agha I (2021)
Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia.
Cancers; 13(24):6157.
Go to publication

See more

Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C, Chabannon C, Ciceri F, Corbacioglu S, Ellard R, Sanchez-Guijo F, Jäger U, Hildebrandt M, Hudecek M et al. (2021)
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). 
Ann Oncol; S0923-7534(21)04876-6. 
Go to publication

Luu, M, Visekruna, A (2021)
Microbial metabolites: novel therapeutic tools for boosting cancer therapies.
Trends in Cell Biology, Volume 31, Issue 11.
Go to publication

Jetani, H, Navarro-Bailón, A, Maucheret, M et al. (2021)
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML).
Blood 2021.
Go to publication

Luu, M, Riester, Z, Baldrich, A et al. (2021)
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer.
Nat Commun 12, 4077.
Go to publication

Prommersberger, S, Reiser, M, Beckmann, J et al. (2021)
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.
Gene Ther 28, 560–571.
Go to publication

Da Vià, M.C., Dietrich, O., Truger, M. et al. (2021)
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.
Nat Med 27, 616–619.
Go to publication

Prommersberger S, Hudecek M, Nerreter T. (2020)
Antibody-Based CAR T Cells Produced by Lentiviral Transduction.
Curr Protoc Immunol. Mar;128(1):e93.

Go to publication

  • Logo of the Comprehensive Cancer Center Mainfranken
  • Logo des Vereins Forschung hilft
  • Logo of the Bayerische Akademie der Wissenschaften
  • Logo of the Bundesministerium für Bildung und Forschung
  • Logo der Deutschen Forschungsgemeinschaft DFG
  • Logo of the project H2020
  • Logo of Hilfe im Kampf gegen den Krebs e.V.
  • Logo of the Interdisziplinäres Zentrum für Klinische Forschung
  • Logo of the José Carreras foundation
  • Logo of Deutsche Krebshilfe
  • Logo of m4 Personalisierte Medizin e.V.
  • Logo of Marie Skłodowska-Curie Actions
  • Logo of Myeloma Crowd
  • Logo der Helmholtz-Gemeinschaft Deutscher Forschungszentren

Contact person

Portraitfoto von Univ.-Prof. Dr. med. Michael Hudecek

Univ.-Prof. Dr. med.
Michael Hudecek

Director and Research Group Leader Translational CAR-T Research Program


Department of Internal Medicine II | Oberdürrbacher Straße 6 | 97080 Würzburg | Germany